Illumina launches TruSeq taste preparation, Exome Enrichment kits looking for sequencing studies

Illumina, Inc. (NASDAQ:ILMN) today announced TruSeq sample preparation kits in the service of DNA, RNA, and teeny RNA applications and the TruSeq Exome Enrichment Kit, against ingest across the group's portfolio of sequencing platforms. TruSeq sequencing reagents present a smooth workflow that is scrimping and scalable, delivering industry-leading loosely precision for sequencing studies.

“The RNA Sample Prep Kit allows us to acknowledge Aciclovir herpes simplex unshortened drop of the increased sequencing achieve of our Illumina instruments”

The benefits of TruSeq are parlous in place of our customers who are routinely generating more than 300 Gb per run with their HiSeq systems, said Christian Henry, Accustomed Head of Lifestyle Sciences seeking Illumina. As we extend to scope the crop of our HiSeq systems, the multiplexing potential and economics of TruSeq solutions inclination adorn come of even more important. Illumina is committed to continuing modernization in sequencing to cure our customers do more and publish even faster. In factors, the 1,000th mull over using Illumina sequencing was published in October.

TruSeq Sample Prep kits feature master-mixed reagents and optimized adapter plan, making the sedulousness's most simplified sequencing workflow sober-sided easier. TruSeq Exome Enrichment kits, used with TruSeq DNA Representation Prep kits, enable large-scale exome studies using a pre-enrichment pooling nearly equal with plate-based processing of up to 96 samples.

The RNA Sample Prep Trappings allows us to obtain shapely gain of the increased sequencing harvest of our Illumina instruments, said Greg May, President and COO at the Nationwide Center looking for Genomic Resources. RNA-seq is contemporarily cost-competitive with microarrays, allowing the pattern of reasonably priced, rigorous gene mien experiments with devote sampling sizes fo r statistical analysis.

TruSeq solutions accommodate:

Coverage of greater than 62 Mb of the considerate exome, with an industry-leading appraisal of less than $300 per sample enrichment.
A adaptable proposition for single-end, paired-end, and multiplexed sequencing with as much as 80% reduction in cost out instead of sample prep.
Sequencing-based gene voicing studies with richer data sets, a simpler workflow, and a downgrade bonus than arrays.
A means in behalf of researchers to bind up to 48 samples into a single sequencing lane, profiling the whole spectrum of young RNAs with the highest kind-heartedness and specificity.